Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Epilepsy

  Free Subscription


Articles published in J Neurol Sci

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    June 2021
  1. SAIRANEN JJ, Kantanen AM, Hyppola HT, Kalviainen RK, et al
    Status epilepticus: Practice variation and adherence to treatment guideline in a large community hospital.
    J Neurol Sci. 2021;427:117542.
    PubMed     Abstract available


  2. BUSTOS J, Gonzales I, Saavedra H, Handali S, et al
    Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.
    J Neurol Sci. 2021;427:117527.
    PubMed     Abstract available


    May 2021
  3. SHLOBIN NA, Singh G, Newton CR, Sander JW, et al
    Classifying epilepsy pragmatically: Past, present, and future.
    J Neurol Sci. 2021;427:117515.
    PubMed     Abstract available


  4. VANNICOLA C, Tassi L, Barba C, Boniver C, et al
    Seizure outcome after epilepsy surgery in tuberous sclerosis complex: Results and analysis of predictors from a multicenter study.
    J Neurol Sci. 2021;427:117506.
    PubMed     Abstract available


  5. AJINKYA S, Fox J, Lekoubou A
    Contemporary trends in antiepileptic drug treatment among women of childbearing age with epilepsy in the United States: 2004-2015.
    J Neurol Sci. 2021;427:117500.
    PubMed     Abstract available


  6. KONDAJJI AM, Evans A, Lum M, Kulinich D, et al
    A systematic review of stereotactic radiofrequency ablation for hypothalamic hamartomas.
    J Neurol Sci. 2021;424:117428.
    PubMed     Abstract available


  7. RIVA A, Orsini A, Scala M, Taramasso V, et al
    Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations.
    J Neurol Sci. 2021;424:117409.
    PubMed     Abstract available


    March 2021
  8. HEUGENHAUSER J, Iglseder S, Muigg A, Kerschbaumer J, et al
    Perampanel in brain tumor and SMART-syndrome related epilepsy - A single institutional experience.
    J Neurol Sci. 2021;423:117386.
    PubMed     Abstract available


    February 2021
  9. LLAURADO A, Quintana M, Ballve A, Campos D, et al
    Factors associated with resistance to benzodiazepines in status epilepticus.
    J Neurol Sci. 2021;423:117368.
    PubMed     Abstract available


  10. LUNA J, Metanmo S, Boumediene F, Mbelesso P, et al
    Onchocerciasis in tropical neurology: A scoping review.
    J Neurol Sci. 2021;421:117314.
    PubMed     Abstract available


    November 2020
  11. LEKOUBOU A, Bishu KG, Ovbiagele B
    Early-hospital readmission after generalized status epilepticus during stroke hospitalization.
    J Neurol Sci. 2020;420:117258.
    PubMed     Abstract available


  12. ALSHERBINI K, Abhi Pandhi F, Goyanes J, Deep A, et al
    A retrospective, observational study of perampanel in refractory and super-refractory status epilepticus.
    J Neurol Sci. 2020;419:117214.
    PubMed     Abstract available


    September 2020
  13. SARFO FS, Akassi J, Obese V, Adamu S, et al
    Prevalence and predictors of post-stroke epilepsy among Ghanaian stroke survivors.
    J Neurol Sci. 2020;418:117138.
    PubMed     Abstract available


    August 2020
  14. IZZI F, Placidi F, Liguori C, Posca I, et al
    Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy.
    J Neurol Sci. 2020;418:117095.
    PubMed     Abstract available


    July 2020
  15. KUNII M, Doi H, Hashiguchi S, Matsuishi T, et al
    De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies.
    J Neurol Sci. 2020;416:117047.
    PubMed     Abstract available


    May 2020
  16. CERULLI IRELLI E, Cocchi E, Morano A, Casciato S, et al
    Valproate impact and sex-dependent seizure remission in patients with idiopathic generalized epilepsy.
    J Neurol Sci. 2020;415:116940.
    PubMed     Abstract available


  17. PASCARELLA A, Iannone LF, Di Gennaro G, D'Aniello A, et al
    The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a "real world" context: focus on temporal lobe epilepsy.
    J Neurol Sci. 2020;415:116903.
    PubMed     Abstract available


  18. GOMEZ-IBANEZ A, Garces-Sanchez M, Hampel KG, Cano-Lopez I, et al
    Epilepsy surgery beyond 50years: Long-term seizure and cognitive outcomes.
    J Neurol Sci. 2020;414:116872.
    PubMed     Abstract available


    April 2020
  19. AUNG TT, Murayi R, Aung T, Murakami H, et al
    Prospective use of MRI post-processing in the surgical treatment of MRI-negative orbitofrontal epilepsy.
    J Neurol Sci. 2020;414:116828.
    PubMed    


    March 2020
  20. MOALONG KMC, Espiritu AI, Fernandez MLL
    Efficacy and tolerability of intravenous brivaracetam for status epilepticus: A systematic review.
    J Neurol Sci. 2020;413:116799.
    PubMed     Abstract available


    February 2020
  21. ZUTSHI D, Yarraguntla K, Mahulikar A, Seraji-Bozorgzad N, et al
    Racial variations in lacosamide serum concentrations in adult patients with epilepsy.
    J Neurol Sci. 2020;412:116742.
    PubMed     Abstract available


    January 2020
  22. MANFREDONIA F, Saturno E, Lawley A, Gasverde S, et al
    Prevalence and clinical correlates of non-convulsive status epilepticus in elderly patients with acute confusional state: A systematic literature review.
    J Neurol Sci. 2020;410:116674.
    PubMed     Abstract available


    December 2019
  23. XU C, Ma K, Zhang X, Yu T, et al
    Ictal coprolalia occurs due to the activation of the temporal-orbitofrontal network in patients with epilepsy.
    J Neurol Sci. 2019;409:116634.
    PubMed     Abstract available


    November 2019
  24. CHANG RS, Lui HKK, Lui HTC, Leung CYW, et al
    Efficacy upon 12-weeks after achievement of maximal dose and tolerability of lacosamide as an adjunctive therapy in epilepsy: Real world clinical experience.
    J Neurol Sci. 2019;409:116601.
    PubMed     Abstract available


    October 2019
  25. FOX J, Ajinkya S, Greenblatt A, Houston P, et al
    Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases.
    J Neurol Sci. 2019;407:116538.
    PubMed     Abstract available


    August 2019
  26. CHANG RS, Lui HKK, Leung YHI, Leung WCY, et al
    Efficacy and tolerability of perampanel as an adjunct therapy in refractory epilepsy from real-world experience.
    J Neurol Sci. 2019;405:116416.
    PubMed    


    June 2019
  27. QIU X, Lai W, Kinoshita M, Zhang L, et al
    Trends in epilepsy diagnosis and surgery in western China during 2009-2017.
    J Neurol Sci. 2019;403:153-158.
    PubMed     Abstract available


    May 2019
  28. DOHERTY CP, Rheims S, Assenza G, Boero G, et al
    Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.
    J Neurol Sci. 2019;402:88-99.
    PubMed     Abstract available


    March 2019
  29. STOLLBERGER C, Finsterer J
    Seizure-triggered Takotsubo syndrome - A need for cooperation between neurologists and cardiologists.
    J Neurol Sci. 2019;398:193.
    PubMed    


  30. BINAGHI G, Pasqualucci D, Porcu M
    A systematic cardiological screening for seizure-triggered Takotsubo is really useful?
    J Neurol Sci. 2019;398:192.
    PubMed    


  31. GINATEMPO F, Fois C, De Carli F, Todesco S, et al
    Effect of short-term transcutaneous trigeminal nerve stimulation on EEG activity in drug-resistant epilepsy.
    J Neurol Sci. 2019;400:90-96.
    PubMed     Abstract available


    January 2019
  32. REYES-GARCIA SZ, Scorza CA, Ortiz-Villatoro NN, Cavalheiro EA, et al
    Losartan fails to suppress epileptiform activity in brain slices from resected tissues of patients with drug resistant epilepsy.
    J Neurol Sci. 2019;397:169-171.
    PubMed    


    December 2018
  33. ZHANG X, Zhang G, Ma K, Yu T, et al
    A case of right orbitofrontal epilepsy featuring ictal swearing.
    J Neurol Sci. 2018;397:1-3.
    PubMed    


  34. STOLLBERGER C, Sauerberg M, Finsterer J
    Immediate versus delayed detection of Takotsubo syndrome after epileptic seizures.
    J Neurol Sci. 2018;397:42-47.
    PubMed     Abstract available


    October 2018
  35. CASCIATO S, Morano A, Fattouch J, Fanella M, et al
    Factors underlying the development of chronic temporal lobe epilepsy in autoimmune encephalitis.
    J Neurol Sci. 2018;396:102-107.
    PubMed     Abstract available


  36. HAMANO SI, Sugai K, Miki M, Tabata T, et al
    Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus.
    J Neurol Sci. 2018;396:150-158.
    PubMed     Abstract available


    September 2018
  37. KAWAKAMI O, Koike Y, Ando T, Sugiura M, et al
    Incidence of dementia in patients with adult-onset epilepsy of unknown causes.
    J Neurol Sci. 2018;395:71-76.
    PubMed    


  38. GAMELEIRA FT, Alucio KT, de Paiva MLMN, de Lima Carlos KC, et al
    Epileptic chorea: Another window into neural networks?
    J Neurol Sci. 2018;394:138-140.
    PubMed    


  39. TOMKINSON C, Lu JQ
    Response to: Towards an integrated functional and epileptological approach in the management of meningioangiomatosis.
    J Neurol Sci. 2018 Sep 7. pii: S0022-510X(18)30358.
    PubMed    


  40. ROUX A, Zanello M, Pallud J
    Towards an integrated functional and epileptological approach in the management of meningioangiomatosis.
    J Neurol Sci. 2018;394:57.
    PubMed    


    August 2018
  41. SONG J, Swallow E, Said Q, Peeples M, et al
    Epilepsy treatment patterns among patients with tuberous sclerosis complex.
    J Neurol Sci. 2018;391:104-108.
    PubMed     Abstract available


    July 2018
  42. ALMALLOUHI E, Rahwan M, Kutluay E
    Myoclonic status epilepticus as an initial presentation of acute biliary pancreatitis.
    J Neurol Sci. 2018;392:139-141.
    PubMed    


  43. MORANO A, Fattouch J, Albini M, Casciato S, et al
    Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre.
    J Neurol Sci. 2018;390:67-74.
    PubMed     Abstract available


    March 2018
  44. ZHU X, He Z, Luo C, Qiu X, et al
    Altered spontaneous brain activity in MRI-negative refractory temporal lobe epilepsy patients with major depressive disorder: A resting-state fMRI study.
    J Neurol Sci. 2018;386:29-35.
    PubMed     Abstract available


    January 2018
  45. LEKOUBOU A, Bishu KG, Ovbiagele B
    Nationwide trends in medical expenditures among adults with epilepsy: 2003-2014.
    J Neurol Sci. 2018;384:113-120.
    PubMed     Abstract available


    November 2017
  46. MIKI Y, Tanji K, Kimura K, Yajima N, et al
    Status epilepticus causing extensive microvacuolar change with astrocytosis and diffusion MRI abnormalities in the subcortical white matter.
    J Neurol Sci. 2017;382:55-57.
    PubMed    


  47. BRAUN J, Gau E, Revelle S, Byrne L, et al
    Impact of non-guideline-based treatment of status epilepticus.
    J Neurol Sci. 2017;382:126-130.
    PubMed     Abstract available


    October 2017
  48. ALLONE C, Lo Buono V, Corallo F, Pisani LR, et al
    Neuroimaging and cognitive functions in temporal lobe epilepsy: A review of the literature.
    J Neurol Sci. 2017;381:7-15.
    PubMed     Abstract available


  49. NARDETTO L, Zoccarato M, Santelli L, Tiberio I, et al
    18F-FDG PET/MRI in cryptogenic new-onset refractory status epilepticus: a potential marker of disease location, activity and prognosis?
    J Neurol Sci. 2017;381:100-102.
    PubMed    


    August 2017
  50. BIANUCCI R, Charlier P, Evans P, Appenzeller O, et al
    Temporal lobe epilepsy and anorexia nervosa in St. Catherine of Siena (1347-1380).
    J Neurol Sci. 2017;379:122-123.
    PubMed    


    May 2017
  51. LEYVA IR, Gomez JFH, Enriquez FC, Sierra JFH, et al
    Usefulness of Ilae 2010 classification in Mexican epilepsy patients.
    J Neurol Sci. 2017;376:13-15.
    PubMed     Abstract available


    April 2017
  52. NAMVAR S, Fathollahi Y, Javan M, Zeraati M, et al
    The antiepileptogenic effect of low-frequency stimulation on perforant path kindling involves changes in regulators of G-protein signaling in rat.
    J Neurol Sci. 2017;375:450-459.
    PubMed     Abstract available


  53. ZHANG Y, Huang Y, Wang G, Wang X, et al
    Inhibition of 17-beta-estradiol on neuronal excitability via enhancing GIRK1-mediated inwardly rectifying potassium currents and GIRK1 expression.
    J Neurol Sci. 2017;375:335-341.
    PubMed     Abstract available


  54. KAMIYA-MATSUOKA C, Tummala S
    Electrographic patterns in patients with posterior reversible encephalopathy syndrome and seizures.
    J Neurol Sci. 2017;375:294-298.
    PubMed     Abstract available


  55. ALI R, Elsayed M, Kaur M, Air E, et al
    Use of social media to assess the effectiveness of vagal nerve stimulation in Dravet syndrome: A caregiver's perspective.
    J Neurol Sci. 2017;375:146-149.
    PubMed     Abstract available


    February 2017
  56. AHMAD A, Dad R, Ullah MI, Baig TA, et al
    Clinical and genetic studies in patients with Lafora disease from Pakistan.
    J Neurol Sci. 2017;373:263-267.
    PubMed     Abstract available


    January 2017
  57. SPENCER PS, Mazumder R, Palmer VS
    Response to R. Colebunders: Helminth infections in Nodding syndrome.
    J Neurol Sci. 2017;372:441.
    PubMed    


    August 2016
  58. RIZVI S, Hernandez-Ronquillo L, Moien-Afshari F, Hunter G, et al
    Evaluating the single seizure clinic model: Findings from a Canadian Center.
    J Neurol Sci. 2016;367:203-10.
    PubMed     Abstract available


  59. CHOI JY, Kim JE, Han JH, Yun CH, et al
    Cerebral macrokinetopsia: Exaggerated perception of retinal image motion.
    J Neurol Sci. 2016;367:128-30.
    PubMed    


    July 2016
  60. FUJITA Y, Takanashi J, Takei H, Ota S, et al
    Activated microglia in acute encephalopathy with biphasic seizures and late reduced diffusion.
    J Neurol Sci. 2016;366:91-3.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: